Diabetes 51:522-527, 2002
© 2002 by the American Diabetes Association, Inc.
Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes
Yong K. Kim,
Mi-S. Lee,
Seok M. Son,
In J. Kim,
Won S. Lee,
Byung Y. Rhim,
Ki W. Hong, and
Chi D. Kim
From the Department of Internal Medicine and Pharmacology, College of Medicine, Pusan National University, Pusan, South Korea
Superoxide anion can modulate vascular smooth muscle tone and is potentially involved in diabetic vascular complications. The present study was undertaken to characterize both vascular production and the enzymatic source of superoxide anion in type 2 diabetic rats. In the thoracic aorta of OLETF rats, endothelium-dependent relaxation was markedly attenuated compared with that of control (LETO) rats in association with a significant increase in superoxide production (2,421.39 ± 407.01 nmol · min-1 · mg-1). The increased production of superoxide anion was significantly attenuated by diphenyleneiodonium (DPI; 10 µmol/l), an inhibitor of NAD(P)H oxidase. The production of superoxide anion in response to NADH as a substrate was markedly increased in the vascular homogenates, but NADPH, arachidonic acid, xanthine, and succinate produced only small increases in chemiluminescence. In line with these results, studies using various enzyme inhibitors, such as DPI, allopurinol, rotenone, NG-monomethyl-L-arginine, and indomethacin, suggest that the predominant source of superoxide anion in vascular particulate fraction is NADH-dependent membrane-bound oxidase. Furthermore, the expression of p22phox, a major component of vascular NAD(P)H oxidase, was markedly increased in the aorta from OLETF rats compared with that of LETO rats. These findings suggest that upregulated expression of p22phox mRNA and enhanced NADH oxidase activity contribute to the impaired endothelium-dependent vasodilation in OLETF rats.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. R. Duncan, P. A. Crossey, S. Walker, N. Anilkumar, L. Poston, G. Douglas, V. A. Ezzat, S. B. Wheatcroft, A. M. Shah, and M. I. Kearney
Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo
Diabetes,
December 1, 2008;
57(12):
3307 - 3314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Martin, P. Du, A. Dikalova, B. Lassegue, M. Aleman, M. C. Gongora, K. Brown, G. Joseph, D. G. Harrison, W. R. Taylor, et al.
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2073 - H2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Angermayr, M. Fernandez, M. Mejias, J. Gracia-Sancho, J. C. Garcia-Pagan, and J. Bosch
NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats
Gut,
April 1, 2007;
56(4):
560 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Minamiyama, Y. Bito, S. Takemura, Y. Takahashi, S. Kodai, S. Mizuguchi, Y. Nishikawa, S. Suehiro, and S. Okada
Calorie Restriction Improves Cardiovascular Risk Factors via Reduction of Mitochondrial Reactive Oxygen Species in Type II Diabetic Rats
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
535 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rahman, A. Nishiyama, P. Guo, Y. Nagai, G.-X. Zhang, Y. Fujisawa, Y.-Y. Fan, S. Kimura, N. Hosomi, K. Omori, et al.
Effects of Adrenomedullin on Cardiac Oxidative Stress and Collagen Accumulation in Aldosterone-Dependent Malignant Hypertensive Rats
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
1323 - 1329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Taniyama, H. Hitomi, A. Shah, R. W. Alexander, and K. K. Griendling
Mechanisms of Reactive Oxygen Species-Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1142 - 1147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2005;
25(3):
487 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-D. Luo, Y.-Y. Wang, W.-L. Fu, J. Wu, and A. F. Chen
Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice
Circulation,
October 19, 2004;
110(16):
2484 - 2493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wassmann, K. Wassmann, and G. Nickenig
Modulation of Oxidant and Antioxidant Enzyme Expression and Function in Vascular Cells
Hypertension,
October 1, 2004;
44(4):
381 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Endemann and E. L. Schiffrin
Endothelial Dysfunction
J. Am. Soc. Nephrol.,
August 1, 2004;
15(8):
1983 - 1992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, T. Matsumoto, K. Ooishi, and K. Kamata
Differential expression of {alpha}2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats
Am J Physiol Heart Circ Physiol,
July 1, 2004;
287(1):
H135 - H148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Taniyama and K. K. Griendling
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Hypertension,
December 1, 2003;
42(6):
1075 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Griendling and G. A. FitzGerald
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Circulation,
October 28, 2003;
108(17):
2034 - 2040.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kitada, D. Koya, T. Sugimoto, M. Isono, S.-i. Araki, A. Kashiwagi, and M. Haneda
Translocation of Glomerular p47phox and p67phox by Protein Kinase C-{beta} Activation Is Required for Oxidative Stress in Diabetic Nephropathy
Diabetes,
October 1, 2003;
52(10):
2603 - 2614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hua, S. Munk, H. Goldberg, I. G. Fantus, and C. I. Whiteside
High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells
J. Biol. Chem.,
September 5, 2003;
278(36):
33951 - 33962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lassegue and R. E. Clempus
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2003;
285(2):
R277 - R297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Inoguchi, T. Sonta, H. Tsubouchi, T. Etoh, M. Kakimoto, N. Sonoda, N. Sato, N. Sekiguchi, K. Kobayashi, H. Sumimoto, et al.
Protein Kinase C-Dependent Increase in Reactive Oxygen Species (ROS) Production in Vascular Tissues of Diabetes: Role of Vascular NAD(P)H Oxidase
J. Am. Soc. Nephrol.,
August 1, 2003;
14(90003):
S227 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Avogaro, E. Pagnin, and L. Calo
Monocyte NADPH Oxidase Subunit p22phox and Inducible Hemeoxygenase-1 Gene Expressions Are Increased in Type II Diabetic Patients: Relationship with Oxidative Stress
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1753 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hayaishi-Okano, Y. Yamasaki, Y. Kajimoto, K.'y. Sakamoto, K. Ohtoshi, N. Katakami, D. Kawamori, T. Miyatsuka, M. Hatazaki, Y. Hazama, et al.
Association of NAD(P)H Oxidase p22 phox Gene Variation With Advanced Carotid Atherosclerosis in Japanese Type 2 Diabetes
Diabetes Care,
February 1, 2003;
26(2):
458 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christ, J. Bauersachs, C. Liebetrau, M. Heck, A. Gunther, and M. Wehling
Glucose Increases Endothelial-Dependent Superoxide Formation in Coronary Arteries by NAD(P)H Oxidase Activation: Attenuation by the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Atorvastatin
Diabetes,
August 1, 2002;
51(8):
2648 - 2652.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|